Treatment of Severe Relapsing-Remitting Multiple Sclerosis with High-Dose Immunosuppressive Therapy and Autologous Hematopoietic Cell Transplantation: 2-Year Follow-up Results of the HALT MS Clinical Trial (Immune Tolerance Network: ITN033AI)

Autor: Nash, Richard, Hutton, George J., Racke, Michael, Popat, Uday, Devine, Steven M., Georges, George, Griffith, Linda, Muraro, Paolo A., Openshaw, Harry, Sayre, Peter, Stuve, Olaf, Arnold, Douglas, Spychala, Meagan, Lim, Noha, Malhotra, Sachin, Phippard, Deborah, Wundes, Annette, Kraft, George H., Bowen, James D.
Zdroj: In Biology of Blood and Marrow Transplantation February 2013 19(2) Supplement:S129-S129
Databáze: ScienceDirect